Please login to the form below

Not currently logged in
Email:
Password:

New accounts: January

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October 2004 to December 2004 inclusive.

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October 2004 to December 2004 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry please email nhobson@pmlive.com

Client

Product

Therapeutic area

Winning agency

Alliance Pharmaceuticals

Alphaderm

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Aquadrate

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Acnisal

Dermatology

RFA Advertising

Alliance Pharmaceuticals

Occlusal

Dermatology

RFA Advertising

AstraZeneca

Arimidex

Oncology

Brader Perryman

Amgen (Europe)

Aranesp

Anaemia

central branding

AstraZeneca

Nexium

Gastroenterology

RFA Advertising

Biogen

Avonex

Multiple sclerosis

Brader Perryman

Cambridge Laboratories

Gelclair

Oncology/ENT

RFA Advertising

Cambridge Laboratories

ImmuCyst

Oncology

RFA Advertising

Eden Biodesign

N/A

Corporate

Affiniti (UK)

Eli Lilly

Gemzar

Oncology

GSW-W

Novartis

Prexige

Osteoarthritis

Brader Perryman

Novartis

Exelon

Alzheimer's disease

Brader Perryman

Takeda

N/A

Corporate

Brader Perryman

Takeda

Actos

Diabetes

Brader Perryman

Takeda

Amias

Hypertension

Brader Perryman

Wyeth

Prostap

Gynaecology

Woolley Pau



2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics